Add BrightSurf on Google Email

Wellcome Trust Sanger Institute


Why are sloths so slow? It’s in their DNA

Researchers have sequenced and analyzed the two-toed sloth genome, discovering unique 'jumping genes' that are likely linked to their slow metabolism. These genes, which have been conserved over millions of years, may hold clues to understanding human health conditions such as diabetes, aging-related disorders, and muscle wasting.

SourceWellcome Trust Sanger Institute·JournalBMC Biology·DateJun 9, 2026

Decades-long study reveals how blood cancers evolve and why some patients' disease worsens

Researchers tracked 30 patients with chronic blood cancers over time, finding that those whose disease remained stable had 'steady' blood cells without additional mutations. Conversely, those with progressing diseases developed changes in DNA years before symptoms worsened. This challenges current views on diagnosing patients without t...

SourceWellcome Trust Sanger Institute·JournalCancer Discovery·DateApr 20, 2026

Largest study of nose microbiome helps highlight those at risk of staph aureus infection

The largest-ever study of the nasal microbiome found that persistent carriers have a distinct microbiome with an abundance of Staphylococcus aureus and a lack of other species, while certain bacteria may help resist S. aureus colonization in non-carriers. The study also identified patterns in the nasal microbiome and used machine learn...

SourceWellcome Trust Sanger Institute·JournalNature Communications·DateDec 2, 2025

Sanger Institute: Origins of the ‘London Underground mosquito’ uncovered, shedding light on West Nile virus transmission

New research has revealed that the 'London Underground mosquito' evolved over 1,000 years ago in Ancient Egypt, contradicting a long-held theory of its emergence in northern Europe. The study's findings suggest that hybridisation between human-biting and bird-biting mosquitoes may contribute to West Nile virus transmission.

New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects

Researchers analyzed blood cell genomes from 23 patients treated with various chemotherapies, discovering new patterns of DNA damage and mutational signatures associated with specific drugs. The study suggests using genomic data to choose chemotherapies that minimize premature ageing and potential secondary cancer risks.

SourceWellcome Trust Sanger Institute·JournalNature Genetics·DateJul 1, 2025

Genetic ancestry and parental smoking linked to new genetic changes in children

Research reveals that different ancestry groups have varying rates of new genetic mutations passed to children, with African groups showing a higher rate. Additionally, parental age, especially paternal age, significantly impacts the number of new genetic mutations, while parental smoking is linked to a small increase in mutation count.

SourceWellcome Trust Sanger Institute·JournalNature Communications·DateMay 15, 2025